Works matching IS 02620898 AND DT 2025 AND VI 42 AND IP 2


Results: 9
    1

    Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2<sup>EV</sup> study.

    Published in:
    Clinical & Experimental Metastasis, 2025, v. 42, n. 2, p. 1, doi. 10.1007/s10585-025-10335-4
    By:
    • Fiala, Ondřej;
    • Buti, Sebastiano;
    • Fujita, Kazutoshi;
    • de Liaño, Alfonso Gómez;
    • Fukuokaya, Wataru;
    • Kimura, Takahiro;
    • Yanagisawa, Takafumi;
    • Giannatempo, Patrizia;
    • Angel, Martin;
    • Mennitto, Alessia;
    • Molina-Cerrillo, Javier;
    • Bourlon, Maria T.;
    • Soares, Andrey;
    • Takeshita, Hideki;
    • Calabrò, Fabio;
    • Ortega, Cinzia;
    • Kucharz, Jakub;
    • Milella, Michele;
    • Seront, Emmanuel;
    • Park, Se Hoon
    Publication type:
    Article
    2

    The clinical benefit of adding radiotherapy to ipilimumab in patients with melanoma brain metastasis: a systematic review and meta-analysis.

    Published in:
    Clinical & Experimental Metastasis, 2025, v. 42, n. 2, p. 1, doi. 10.1007/s10585-025-10333-6
    By:
    • Habibi, Mohammad Amin;
    • Delbari, Pouria;
    • Rashidi, Farhang;
    • Hajikarimloo, Bardia;
    • Allahdadi, Ali;
    • Rouzrokh, Saghar;
    • Shahir Eftekhar, Mohammad;
    • Habibzadeh, Adrina;
    • Khanmirzaei, Amir;
    • Ebrahimi, Pouya;
    • Mohammadzadeh, Ibrahim;
    • Naseri Alavi, Seyed Ahmad
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9